HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Beneficial synergistic effects of concurrent treatment with theanine and caffeine against cerebral ischemia-reperfusion injury in rats.

Abstract
Theanine and caffeine, 2 naturally occurring components in tea, have repeatedly been shown to deliver unique cognitive benefits when consumed in combination. In this study, we assessed the beneficial synergistic effects of concurrent treatment with theanine and caffeine against cerebral damage in rats. Theanine and caffeine had no effect on physiological variables, including pH, partial pressures of oxygen (PaO2) and carbon dioxide (PaCO2), mean arterial blood pressure, plasma glucose, or regional cerebral blood flow. Treatment with theanine (1 mg/kg body mass, intraperitoneal injection) alone significantly reduced cerebral infarction induced by cerebral ischemia-reperfusion, but caffeine (10 mg/kg, intravenous administration) alone only had a marginal effect. However, the combination of theanine plus caffeine resulted in a significant reduction of cerebral infarction and brain edema compared with theanine monotherapy. Meanwhile, increased malondialdehyde levels as well as decreased superoxide dismutase activity, glutathione peroxidase activity, and glutathione levels observed in the cerebral cortex after cerebral ischemia-reperfusion were significantly ameliorated by the combination therapy. Furthermore, the elevated inflammatory response levels observed in the cortex after cerebral ischemia-reperfusion were markedly attenuated by the combined treatment. Thus, it is suggested that the neuroprotective potential of a combination therapy with theanine and caffeine against cerebral ischemia-reperfusion is partly ascribed to their antioxidant and anti-inflammatory properties.
AuthorsLingyan Sun, Xia Tian, Lingshan Gou, Xin Ling, Ling Wang, Yan Feng, Xiaoxing Yin, Yi Liu
JournalCanadian journal of physiology and pharmacology (Can J Physiol Pharmacol) Vol. 91 Issue 7 Pg. 562-9 (Jul 2013) ISSN: 1205-7541 [Electronic] Canada
PMID23826680 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antioxidants
  • Glutamates
  • Neuroprotective Agents
  • Caffeine
  • Malondialdehyde
  • theanine
  • Glutathione Peroxidase
  • Superoxide Dismutase
  • Glutathione
Topics
  • Animals
  • Antioxidants (pharmacology)
  • Brain Edema (drug therapy, metabolism)
  • Brain Ischemia (drug therapy, metabolism)
  • Caffeine (pharmacology)
  • Cerebral Cortex (drug effects, metabolism)
  • Cerebral Infarction (drug therapy, metabolism)
  • Drug Synergism
  • Glutamates (pharmacology)
  • Glutathione (metabolism)
  • Glutathione Peroxidase (metabolism)
  • Inflammation (drug therapy, metabolism)
  • Male
  • Malondialdehyde (metabolism)
  • Neuroprotective Agents (pharmacology)
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (drug therapy, metabolism)
  • Superoxide Dismutase (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: